99%+ Purity Guarantee

Undergoes independent third-party verification before release. Tested to confirm ≥99% purity.

Buy Semaglutide 5mg Online

Semaglutide is a synthetic GLP-1 receptor agonist for metabolic and endocrine research. It enables investigation of glucose regulation, appetite signaling, and gastrointestinal motility through GLP-1 receptor activation, supporting studies of incretin signaling pathways, energy balance regulation, and integrated central-peripheral metabolic communication.

$38.00

General info
Brand

NOVERA COMPOUNDS

Strength

5mg

CAS

910463-68-2

Chemical Formula

C₁₈₇H₂₉₁N₄₅O₅₉

Molecular weight

4113.6 g/mol

Peptide Sequence

H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-OH

Synonyms

NN9535

Storage

Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.

Disclaimer: Sold as a research-grade lyophilized peptide in dry powder form. Requires reconstitution under controlled laboratory conditions. Reconstitution agents are not included.

For Research Use Only (RUO): Not for human or animal use, consumption, injection, or application. Not for diagnostic, therapeutic, or clinical purposes.

Free Shipping Over $1000

With fast order dispatch

Guaranteed Product Authenticity

All products contain original LOT numbers

Secure SSL
Encryption

Your data is safe with us

No Order
Minimum

Get the exact quantity you need.

Why Novera Compounds?

Advanced synthesis techniques ensure high structural fidelity and ≥99% purity.

Independent laboratories confirm identity, purity, and batch consistency.

Designed for reproducible laboratory and analytical applications.

Products meet Research Use Only (RUO) standards and relevant laboratory regulations.

Certificates of Analysis and quality verification reports provided for every lot.

555a76c773c8ed79615174887299fb4c5c66d2ad

 

Semaglutide 5mg – About This Product

Semaglutide 5mg is a synthetic GLP-1 receptor agonistpeptide developed through recombinant DNA technology, designed to mimic the activity of native human GLP-1. The peptide shares94% structural homologywith human GLP-1(7-37) and contains two critical amino acid substitutions: aminoisobutyric acid (Aib) at position 8 and arginine (Arg) at position 34.

Additionally, lysine at position 26 is modified through acylation with a spacer consisting of glutamic acid and oxyethylene linker moieties, and a C18 fatty di-acid chain. These structural modifications work synergistically: the Aib8 substitution confers resistance to dipeptidyl peptidase-4 (DPP-4) degradation while maintaining receptor potency, while the Lys26 acylation with the C18 fatty di-acid enhances albumin binding and extends the peptide’s half-life in circulation.

It also includes a modified lysine residuelinked to a C18 diacid chain. These structural features strengthen resistance to DPP-4 degradation and support extended stability in controlled research environments.

With a molecular weight of approximately 4113.58 g/mol, semaglutide GLP-1 peptideis provided as a high-purity, lyophilized (freeze-dried) powder in a 5 mg vial, designed for laboratory research use. This formulation is commonly used in studies investigating glucose regulation, appetite control, energy metabolism, and metabolic homeostasis in controlled research settings.

Semaglutide 5mg – Key Features and Benefits

Researchers who wish to buy semaglutide should know its notable benefits, making it a promising compound. Semaglutidepeptideis a valuable tool for laboratory research, offering the following characteristics:

  • High Purity: ≥95% purity (verified by HPLC) for consistent and reproducible research results.
  • Stable Formulation: Supplied as a lyophilized powder in a semaglutide 5 mg peptide vial for convenient storage and straightforward reconstitution using bacteriostatic water or sterile saline.
  • Research Applications: Under investigation for effects on glucose metabolism, insulin secretion, appetite regulation, satiety signaling, and energy balance.
  • Extended Stability: The modified structure—combining DPP-4 resistance and albumin-binding fatty acid modification—extends the peptide’s half-life, enabling prolonged research observation periods in controlled laboratory settings.
  • Metabolic Research Focus: Supports research in glucose homeostasis, gastrointestinal signaling, neuroendocrine pathways, and systemic metabolic effects.
  • Well-Characterized: Absorption, distribution, and binding characteristics are extensively documented in peer-reviewed research literature and structural studies.

Semaglutide 5mg Mechanism & Research Applications

Semaglutide activates glucagon-like peptide-1 (GLP-1) receptors, which are expressed in the pancreas, gastrointestinal tract, and brain. In research models, this activation has been associated with the following effects:

  • Glucose Metabolism: Studied for its role in stimulating glucose-dependent insulin secretion from pancreatic β-cells and inhibiting glucagon release, contributing to glucose homeostasis in controlled research environments.
  • Appetite and Satiety Signaling: Investigated for its effects on hypothalamic appetite-regulating neurons and satiety pathways, which may mediate feeding behavior in animal models.
  • Energy Expenditure and Metabolic Rate: Examined for potential effects on thermogenesis, adipose tissue browning, and systemic energy balance in preclinical studies.
  • Gastrointestinal and Neuroendocrine Function: Research examines the effects on gastric emptying, nutrient absorption, and the brain-gut signaling axes involved in metabolic regulation.

Semaglutide 5mg Dosing & Observed Effects in Research

In research settings, semaglutide is typically tested at varying doses depending on the experimental design and model system:

  • Preclinical Models: Rodent studies typically employ doses ranging from 1 to 100 nmol/kg body weight, with commonly used doses between 10–25 nmol/kg for metabolic investigations.
  • Clinical Research (Human Studies): Clinical trials typically begin with 0.25 mg administered once weekly, with dose escalation to maintenance doses of 1.0–2.4 mg weekly depending on study protocol and therapeutic endpoints.
  • Observed Research Findings: In controlled laboratory and clinical settings, semaglutide has been observed to affect glucose concentrations, insulin and glucagon secretion, appetite-related hormones, and lipid metabolism. These observations are reported in peer-reviewed literature and represent findings in research contexts, not therapeutic claims.

Semaglutide 5mg Storage, Safety & References

Storage instructions for semaglutide for research peptide involve:

  • Lyophilized Powder: Store at 2–8°C in sealed vials, protected from light and moisture. Long-term storage at –20°C is acceptable.
  • After Reconstitution: Store reconstituted solutions at 2–8°C. Use within 7–10 days for optimal peptide integrity; limit vial punctures and avoid repeated freeze-thaw cycles.
  • Handling Requirements: Use appropriate laboratory personal protective equipment, including gloves, eye protection, and a lab coat, when handling the peptide.
  • Disposal: Dispose of unused material according to institutional safety protocols and applicable regulations.
  • Safety: Always consult and follow the Safety Data Sheet (SDS) provided with the product.

References

https://www.ncbi.nlm.nih.gov/books/NBK603723

https://pmc.ncbi.nlm.nih.gov/articles/PMC5836914

https://pubchem.ncbi.nlm.nih.gov/compound/Semaglutide

https://pmc.ncbi.nlm.nih.gov/articles/PMC11674233

https://www.biorxiv.org/content/10.1101/2021.01.12.426449

https://pmc.ncbi.nlm.nih.gov/articles/PMC6474072

https://www.rcsb.org/structure/4ZGM

https://pdb101.rcsb.org/global-health/diabetes-mellitus/drugs/incretins/drug/semaglutide/semaglutide

https://www.nature.com/articles/s41591-022-02026-4

https://pubmed.ncbi.nlm.nih.gov/39046272

https://pubmed.ncbi.nlm.nih.gov/34305810

Compliance Notice

This product is intended for laboratory research use only and is not approved for human or veterinary use.